Literature DB >> 27871892

Pso p27, a SERPINB3/B4-derived protein, is most likely a common autoantigen in chronic inflammatory diseases.

Ole-Jan Iversen1, Hilde Lysvand2, Geir Slupphaug3.   

Abstract

Autoimmune diseases are characterized by chronic inflammatory reactions localized to an organ or organ-system. They are caused by loss of immunologic tolerance toward self-antigens, causing formation of autoantibodies that mistakenly attack their own body. Psoriasis is a chronic inflammatory autoimmune skin disease in which the underlying molecular mechanisms remain elusive. In this review, we present evidence accumulated through more than three decades that the serpin-derived protein Pso p27 is an autoantigen in psoriasis and probably also in other chronic inflammatory diseases. Pso p27 is derived from the serpin molecules SERPINB3 and SERPINB4 through non-canonical cleavage by mast cell chymase. In psoriasis, it is exclusively found in skin lesions and not in uninvolved skin. The serpins are cleaved into three fragments that remain associated as a Pso p27 complex with novel immunogenic properties and increased tendency to form large aggregates compared to native SERPINB3/B4. The amount of Pso p27 is directly correlated to disease activity, and through formation of complement activating immune-complexes, Pso p27 contribute to the inflammation in the skin lesions. SERPINB3/B4 are expressed in skin fibroblasts and keratinocytes, but normally absent in mast cells. Overexpression of the serpins may be induced by inflammation and hypoxia, resulting in mast cell uptake via yet unknown mechanisms. Here the generation and subsequent release of Pso p27 aggregates may promote an inflammatory loop that contributes to the chronicity of psoriasis and other autoimmune diseases.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Mast cells; Pso p27; Psoriasis; SERPINB3/B4

Mesh:

Substances:

Year:  2016        PMID: 27871892     DOI: 10.1016/j.clim.2016.11.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

Review 1.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.

Authors:  Wolf-Henning Boehncke; Nicolo Costantino Brembilla
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 2.  Squamous Cell Carcinoma Antigen: Clinical Application and Research Status.

Authors:  Huange Zhu
Journal:  Diagnostics (Basel)       Date:  2022-04-24

3.  Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.

Authors:  Sa Do Kang; Sreejata Chatterjee; Samina Alam; Anna C Salzberg; Janice Milici; Sjoerd H van der Burg; Craig Meyers
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

4.  Protease-activated receptor 2 signaling modulates susceptibility of colonic epithelium to injury through stabilization of YAP in vivo.

Authors:  Longmei He; Yiming Ma; Weiwei Li; Wenxiao Han; Xinhua Zhao; Hongying Wang
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

5.  Transcriptome Analysis of Host Inflammatory Responses to the Ectoparasitic Mite Sarcoptes scabiei var. hominis.

Authors:  Huma Shehwana; Sadaf Ijaz; Abeera Fatima; Shelley Walton; Zafar Iqbal Sheikh; Waseem Haider; Shumaila Naz
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.